Pirbuterol
For other uses, see Maxair.
Systematic (IUPAC) name | |
---|---|
(RS)-6-[2-(tert-butylamino)-1-hydroxyethyl]-2-(hydroxymethyl)pyridin-3-ol | |
Clinical data | |
Trade names | Maxair |
AHFS/Drugs.com | Consumer Drug Information |
MedlinePlus | a601096 |
Pregnancy category |
|
Legal status |
|
Routes of administration | Inhalational |
Identifiers | |
CAS Number | 38029-10-6 |
ATC code | R03AC08 R03CC07 |
PubChem | CID 4845 |
IUPHAR/BPS | 7272 |
DrugBank | DB01291 |
ChemSpider | 4679 |
UNII | OG645J8RVW |
KEGG | D08387 |
ChEMBL | CHEMBL1094966 |
Chemical data | |
Formula | C12H20N2O3 |
Molar mass |
240.30 g/mol 300.3 g/mol (acetate) |
Chirality | 1 : 1 mixture (racemate) |
| |
| |
(what is this?) (verify) |
Pirbuterol (trade name: Maxair) is a beta-2 adrenergic bronchodilator used in the treatment of asthma, available (as pirbuterol acetate) as a breath-activated metered-dose inhaler ("autohaler").
Clinical use
- Asthma - preventative/maintenance medicine
- Asthma - "rescue" medicine for reversal of acute asthma attack
Mode of action
Further information: Beta2-adrenergic agonist
Adverse effects
Further information: Beta2-adrenergic agonist
References
External links
|
|
This article is issued from Wikipedia - version of the Friday, January 29, 2016. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.